Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1065	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1151	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1221	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1230	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1416	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1491	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1526	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1560	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1757	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1782	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	1911	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2137	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2139	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2239	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2286	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2293	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2360	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2472	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2504	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2511	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2517	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2559	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2616	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2711	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2749	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2770	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2825	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	2856	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3069	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3099	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3245	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3272	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3288	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3307	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3313	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3320	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3326	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3332	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3361	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3375	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3389	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3411	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3470	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3607	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3726	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3785	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3823	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3831	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3913	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3924	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	3990	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4182	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4183	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4447	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4450	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4586	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4699	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4736	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4804	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4829	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	4918	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	5036	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	5047	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	5096	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	5143	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	5208	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	5490	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	5874	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	6235	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	6723	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	6752	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	7269	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	7846	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	8883	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	10162	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	11661	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-	12699	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	BENZOATE (CAS# 65-85-0); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y